Senior insider sale
General Counsel at UROGEN PHARMA LTD. — senior position signals high conviction
$172.7K
9.04K shares
What this filing means
SMITH JASON DREW plans to sell 9.04K shares of UROGEN PHARMA LTD. valued at approximately $172.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/9/2025ACC: 0001976408-25-000295
Officer· General Counsel
Since Aug 2020
9.04K
Shares to sell
$172.7K
Approx. market value
6.67K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
RSU
N/A
9/7/2023
6.67KTotal acquired6.67K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/7/2023 | RSU N/A | 6.67K | — |
| Total | 6.67K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
7.52K
Market value
$144.0K
7/28/2025
Planned — Approximate Date
NasdaqPlanned
Units to sell
1.52K
Market value
$28.7K
9/8/2025
Total
Units
9.04K
Value
$172.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/28/2025 | 7.52K | $144.0K | — | Completed |
| Planned — Approximate Date | ||||
9/8/2025 | 1.52K | $28.7K | Nasdaq | Planned |
| Total | 9.04K | $172.7K | ||